Aceragen (FRA:V9Z) Marketable Securities : €0.00 Mil (As of Mar. 2023)

View and export this data going back to . Start your Free Trial

What is Aceragen Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Aceragen's Marketable Securities for the quarter that ended in Mar. 2023 was €0.00 Mil.

Aceragen's annual Marketable Securities declined from Dec. 2020 (€3.70 Mil) to Dec. 2021 (€0.00 Mil) but then stayed the same from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil).

Aceragen Marketable Securities Historical Data

The historical data trend for Aceragen's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aceragen Marketable Securities Chart

Aceragen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Marketable Securities

Get a 7-Day Free Trial

2.50

3.70

Aceragen Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

Aceragen Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Aceragen (FRA:V9Z) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Aceragen Marketable Securities Related Terms

Thank you for viewing the detailed overview of Aceragen's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Aceragen (FRA:V9Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aceragen Inc (FRA:V9Z) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

505 Eagleview Boulevard, Suite 212, Exton, PA, USA, 19341

Website

https://www.aceragen.com

Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

Aceragen (FRA:V9Z) Headlines

No Headlines